Cardiovascular Therapeutics / 2020 / Article / Tab 1 / Review Article
Drug-Coated Balloons versus Everolimus-Eluting Stents in Patients with In-Stent Restenosis: A Pair-Wise Meta-Analysis of Randomized Trials Table 1 Baseline characteristics and Jadad scores of the included studies.
Study, year Type of stents Sample size Age (y) Male % Hypertension, % Diabetes, % Previous MI Previous CABG Dyslipidemia Smoking Follow-up DCB EES DCB EES DCB EES DCB EES DCB EES DCB EES DCB EES DCB EES DCB EES ACG, m Clinical, y DARE, 2018 [5 ] DES and BMS 141 137 66 ± 11 65 ± 10 72% 84% 64% 67% 31% 33% 53% 52% 14% 16% 59% 60% 17% 13% 6 1 Restore, 2018 [4 ] DES 86 86 67 ± 10 66 ± 9 70.9% 72.1% 69.8% 75.6% 50.0% 44.2% 30.2% 25.6% NR NR NR NR 46.5% 43.0% 9 1 RIBS IV, 2015 [9 , 12 ] DES 154 155 66 ± 10 66 ± 10 82.5% 83.9% 71% 78% 49% 43% 60% 60% 4% 7% 73% 66% 59% 75%∗ 6–9 1 RIBS V, 2014 [11 , 14 ] BMS 95 94 67 ± 11 64 ± 12 86.3% 87.2% 72% 72% 32% 20% 47% 50% 10% 11% 71% 78% 58% 56% 6–9 1 SEDUCE, 2014 [10 ] BMS 25 25 67.6 ± 7.7 64.2 ± 11 72% 100% 64% 60% 24% 4% 48% 40% NR NR 96% 96% 21% 12% 9 1 TIS, 2016 [6 , 12 ] BMS 68 68 65.6 ± 11 65.5 ± 11 63.2% 67.7% NR NR 25.0% 26.5% 63.2% 60.3% 4.4% 8.8% NR NR 45.6% 42.7% 12 1
Data are shown as percentage or mean ± standard deviation, unless otherwise stated. DCB, drug-coated balloons; EES, everolimus-eluting stents; DES, drug-eluting stents; BMS, bare-mental stents; MI, myocardial infarction; CABG, coronary artery bypass grafting; NR, not reported; ACG, angiography.